Showing results (31-40 of 359) with videos related to
Sort By:
Pageof 36
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2015
Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOCStefano Severi, Maddalena Sansovini, Annarita Ianniello, et al.Pituitary|April 27, 2007
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature reviewUmberto Goglia, Diego Ferone, Marilena Sidoti, et al.Ecancermedicalscience|July 11, 2017
Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO)Giovanni PaganelliJournal of Neuro-Oncology|June 1, 2005
Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastomaAmerigo Boiardi, Mirco Bartolomei, Antonio Silvani, et al.Cancer Treatment Reviews|December 7, 2010
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomasNicola Fazio, Saverio Cinieri, Katia Lorizzo, et al.Plos One|August 1, 2019
Texture analysis in 177Lu SPECT phantom images: Statistical assessment of uniformity requirements using texture featuresAnna Sarnelli, Emilio Mezzenga, Alessandro Vagheggini, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 2018
Modern Radiopharmaceutical Dosimetry Should Include Robust Biodistribution ReportingAdam L Kesner, Lisa BodeiPET Clinics|March 1, 2023
Neuroendocrine Tumor Therapy Response AssessmentVetri Sudar Jayaprakasam, Lisa BodeiClinical Nuclear Medicine|January 29, 2019
Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CTGary A Ulaner, Lisa BodeiBritish Journal of Haematology|November 6, 2007
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomasPier F Ferrucci, Anna Vanazzi, Chiara M Grana, et al.Pageof 36